Literature DB >> 35768151

Glycolipid Metabolite β-Glucosylceramide Is a Neutrophil Extracellular Trap-Inducing Ligand of Mincle Released during Bacterial Infection and Inflammation.

Atul Sharma1, Arun Chauhan1, Pooja Chauhan1, Dustin L Evans2, Randolph E Szlabick2, Mary O Aaland2, Bibhuti B Mishra1, Jyotika Sharma3.   

Abstract

Neutrophil extracellular traps (NETs) are implicated in host defense and inflammatory pathologies alike. A wide range of pathogen- and host-derived factors are known to induce NETs, yet the knowledge about specific receptor-ligand interactions in this response is limited. We previously reported that macrophage-inducible C-type lectin (Mincle) regulates NET formation. In this article, we identify glycosphingolipid β-glucosylceramide (β-GlcCer) as a specific NET-inducing ligand of Mincle. We found that purified β-GlcCer induced NETs in mouse primary neutrophils in vitro and in vivo, and this effect was abrogated in Mincle deficiency. Cell-free β-GlcCer accumulated in the lungs of pneumonic mice, which correlated with pulmonary NET formation in wild-type, but not in Mincle-/-, mice infected intranasally with Klebsiella pneumoniae Although leukocyte infiltration by β-GlcCer administration in vivo did not require Mincle, NETs induced by this sphingolipid were important for bacterial clearance during Klebsiella infection. Mechanistically, β-GlcCer did not activate reactive oxygen species formation in neutrophils but required autophagy and glycolysis for NET formation, because ATG4 inhibitor NSC185058, as well as glycolysis inhibitor 2-deoxy-d-glucose, abrogated β-GlcCer-induced NETs. Forced autophagy activation by tamoxifen could overcome the inhibitory effect of glycolysis blockage on β-GlcCer-mediated NET formation, suggesting that autophagy activation is sufficient to induce NETs in response to this metabolite in the absence of glycolysis. Finally, β-GlcCer accumulated in the plasma of patients with systemic inflammatory response syndrome, and its levels correlated with the extent of systemic NET formation in these patients. Overall, our results posit β-GlcCer as a potent NET-inducing ligand of Mincle with diagnostic and therapeutic potential in inflammatory disease settings.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35768151      PMCID: PMC9347214          DOI: 10.4049/jimmunol.2100855

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  56 in total

Review 1.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

2.  Glucose availability and glycolytic metabolism dictate glycosphingolipid levels.

Authors:  Morgan Stathem; Subathra Marimuthu; Julie O'Neal; Jeffrey C Rathmell; Jason A Chesney; Levi J Beverly; Leah J Siskind
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

Review 3.  Sphingolipids and their metabolism in physiology and disease.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

4.  Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity.

Authors:  Masahiro Nagata; Yoshihiro Izumi; Eri Ishikawa; Ryoko Kiyotake; Rieko Doi; Satoru Iwai; Zakaria Omahdi; Toshiyuki Yamaji; Tomofumi Miyamoto; Takeshi Bamba; Sho Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

5.  HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.

Authors:  Jean-Marc Tadie; Hong-Beom Bae; Shaoning Jiang; Dae Won Park; Celeste P Bell; Huan Yang; Jean-Francois Pittet; Kevin Tracey; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

6.  Signalome-wide RNAi screen identifies GBA1 as a positive mediator of autophagic cell death.

Authors:  Santosh K Dasari; Shani Bialik; Smadar Levin-Zaidman; Vered Levin-Salomon; Alfred H Merrill; Anthony H Futerman; Adi Kimchi
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

7.  Disrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitment.

Authors:  Kumi Izawa; Akie Maehara; Masamichi Isobe; Yuka Yasuda; Makoto Urai; Yasutaka Hoshino; Keigo Ueno; Toshihiro Matsukawa; Mariko Takahashi; Ayako Kaitani; Emiko Shiba; Ayako Takamori; Shino Uchida; Koichiro Uchida; Keiko Maeda; Nobuhiro Nakano; Yoshinori Yamanishi; Toshihiko Oki; David Voehringer; Axel Roers; Susumu Nakae; Junko Ishikawa; Yuki Kinjo; Toshiaki Shimizu; Hideoki Ogawa; Ko Okumura; Toshio Kitamura; Jiro Kitaura
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

Review 8.  Metabolic Insight of Neutrophils in Health and Disease.

Authors:  Sachin Kumar; Madhu Dikshit
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

9.  Glucosylceramide production maintains colon integrity in response to Bacteroides fragilis toxin-induced colon epithelial cell signaling.

Authors:  Logan Patterson; Jawara Allen; Isabella Posey; Jeremy Joseph Porter Shaw; Pedro Costa-Pinheiro; Susan J Walker; Alexis Gademsey; Xinqun Wu; Shaoguang Wu; Nicholas C Zachos; Todd E Fox; Cynthia L Sears; Mark Kester
Journal:  FASEB J       Date:  2020-10-13       Impact factor: 5.834

10.  Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism.

Authors:  Vlad Serbulea; Clint M Upchurch; Katelyn W Ahern; Gael Bories; Paxton Voigt; Dory E DeWeese; Akshaya K Meher; Thurl E Harris; Norbert Leitinger
Journal:  Mol Metab       Date:  2017-11-07       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.